Insider Trading & Ownership - Fairmount Healthcare Co-Invest L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fairmount Healthcare Co-Invest L.P.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-12-29
Other		2023-12-29
5:00 pm		N/A
N/A		Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner		3,841,518$05,485,719
(Indirect)		View
2023-12-07
Option Award		2023-12-11
5:41 pm		N/A
N/A		Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner		16,667$60016,667
(Indirect)		View
2023-11-24
Conversion		2023-11-28
4:05 pm		N/A
N/A		Spyre Therapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner		3,521,367$04,250,938
(Indirect)		View

Ownership		2023-06-30
5:32 pm		N/A
N/A		Aeglea BioTherapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner		0$0536,284,540
(Indirect)		View